Frederic Feger
Paris, 75012, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Multicenter Flow Cytometry For Acute Myeloid Leukemia Measurable Residual Disease With LAIP/DfN And CD34+CD38- Leukemic Stem Cell-Enriched Populations.
Journal: Journal of visualized experiments : JoVE
Published: August 10, 2026
Efficacy of subcutaneous preemptive rituximab in immune-mediated thrombotic thrombocytopenic purpura: Experience from the first 12 cases.
Journal: American journal of hematology
Published: October 05, 2020
CD28/4-1BB CD123 CAR T cells in blastic plasmacytoid dendritic cell neoplasm.
Journal: Leukemia
Published: September 03, 2019
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
Journal: Blood advances
Published: July 12, 2019
Proportion of Cytotoxic Peripheral Blood Natural Killer Cells and T-Cell Large Granular Lymphocytes in Recurrent Miscarriage and Repeated Implantation Failure: Case-Control Study and Meta-analysis.
Journal: Archivum immunologiae et therapiae experimentalis
Published: November 22, 2018
T-cell prolymphocytic leukemia and tuberculosis: a puzzling association.
Journal: Clinical case reports
Published: December 22, 2016
Efficacy of a rituximab regimen based on B cell depletion in thrombotic thrombocytopenic purpura with suboptimal response to standard treatment: Results of a phase II, multicenter noncomparative study.
Journal: American journal of hematology
Published: July 31, 2016
Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia.
Journal: Nature communications
Published: February 16, 2016
The spectrum of chronic CD8+ T-cell expansions: clinical features in 14 patients.
Journal: PloS one
Published: November 29, 2013
Polyclonal CD8+/CD57+ T cell expansions: clinical significance
Journal: Presse medicale (Paris, France : 1983)
Published: March 12, 2012
Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor.
Journal: European journal of haematology
Published: February 14, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026